Healthcare Services US

US Home Infusion Therapy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Home Infusion Therapy Market Industry Trends and Forecast to 2034: Segmented by (Therapy, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.15 Bn Placeholder estimate
Estimate 2025 $9.70 Bn 43.8% of the global market
Projected 2034 $16.39 Bn 68.9% Adds $6.69 Bn over 9 forecast years
CAGR 2025–2034 6.0% Faster than 37% of 107 Healthcare Services markets here
Key players 5
  • US is 43.78% of the global market.
  • In North America, the largest is US (this report) at $9.70 Bn.
  • Fastest growing: Canada at 7.6% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$6.69 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Home Infusion Therapy Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.15 Bn — —
2025 (base) $9.70 Bn +$549.2 Mn —
2026 (forecast) $10.29 Bn +$582.2 Mn +6%
2027 (forecast) $10.90 Bn +$617.1 Mn +12.4%
2028 (forecast) $11.56 Bn +$654.2 Mn +19.1%
2029 (forecast) $12.25 Bn +$693.4 Mn +26.2%
2030 (forecast) $12.99 Bn +$735.0 Mn +33.8%
2031 (forecast) $13.76 Bn +$779.1 Mn +41.9%
2032 (forecast) $14.59 Bn +$825.9 Mn +50.4%
2033 (forecast) $15.47 Bn +$875.4 Mn +59.4%
2034 (forecast) $16.39 Bn +$927.9 Mn +68.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Home Infusion Therapy Market Analysis at a glance
Market size, 2025$9.70 Bn placeholder estimate
Forecast, 2034$16.39 Bn placeholder estimate
Growth (CAGR), 2025–20346.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTherapy, product and end user (see all)
Key playersOption Care Health, CVS Health, Optum, Inc., BD (Becton, Dickinson), B. Braun (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Home Infusion Therapy Market Analysis Executive Summary

Home infusion therapy gives intravenous or injected medicines, such as antibiotics and biologics, in the patient's home.

Key segments of the home Infusion Therapy market include therapy (Anti-Infectives, Parenteral Nutrition and Specialty Biologics) and product (Infusion Pumps, Services and Supplies).

Bar chart: US Home Infusion Therapy market size, 2024–2034, placeholder estimates. $9.15 Bn in 2024, $9.70 Bn in 2025 and $16.39 Bn in 2034, 6.0% CAGR.
US Home Infusion Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Home Infusion Therapy Market Dynamics

Market Growth Drivers

Patient demand for care closer to home, staff shortages, lower costs than hospital stays and better remote monitoring technology are driving the home Infusion Therapy market. Payment rules for virtual care have become more supportive.

Opportunity

Hospital-level care at home, chronic disease programs and virtual specialist services give the home Infusion Therapy market strong room to grow.

Market Restraints

Uneven reimbursement, rules on licensing across borders, poor internet in some areas and the need for strong clinical oversight hold back the home Infusion Therapy market.

Competitive Landscape for Home Infusion Therapy Market in the US

The home Infusion Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Home Infusion Therapy Market in the US

Home Infusion Therapy in the US: payment

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1]

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how home Infusion Therapy services are delivered and paid for in the US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Home Infusion Therapy right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Home Infusion Therapy in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Home Infusion Therapy market in the US?
Placeholder estimate: about $9.70 Bn in 2025, rising to about $16.39 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Home Infusion Therapy market in the US growing?
Placeholder estimate: about 6.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Home Infusion Therapy market report cover?
The report splits the market by therapy (Anti-Infectives, Parenteral Nutrition, Specialty Biologics, Chemotherapy), product (Infusion Pumps, Services, Supplies) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Home Infusion Therapy market?
Key players include Option Care Health, CVS Health, Optum, Inc., BD (Becton, Dickinson) and B. Braun.
What is driving the Home Infusion Therapy market?
Patient demand for care closer to home, staff shortages, lower costs than hospital stays and better remote monitoring technology are driving the home Infusion Therapy market. Payment rules for virtual care have become more supportive.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How much research is published on Home Infusion Therapy?
PubMed lists 30 papers on Home Infusion Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on home and long-term care

See the topic